Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 15 (HCG15) is a non-protein coding gene located within the major histocompatibility complex (MHC/HLA) region on human chromosome 6[3]. It does not encode a functional protein or receptor but is classified as a long non-coding RNA (lncRNA). The biological function of HCG15 remains unclear; it does not participate in classical HLA protein presentation, immune signaling, or drug interaction. There is no evidence suggesting that HCG15 is a therapeutic target, disease biomarker, or relevant for drug development at this time. Its main importance is as part of the diverse and complex HLA genetic region, which is otherwise critical in immune function, transplantation biology, and disease risk through other classical genes encoding surface proteins[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 15 (non-protein coding) (HCG15).